Arcadia Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Arcadia Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2019 to Q3 2024.
  • Arcadia Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.36M shares, a 0.31% increase year-over-year.
  • Arcadia Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.24M shares, a 106% increase from 2022.
  • Arcadia Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 599K shares, a 12.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.36M +4.24K +0.31% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.36M +4.45K +0.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.36M +497K +57.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 1.24M +638K +106% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 1.36M +746K +121% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 1.36M +804K +145% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 864K +310K +55.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 599K +67.4K +12.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 614K -21.6M -97.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 555K -21.2M -97.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 555K -18.5M -97.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 532K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 22.2M +11.5M +107% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 21.7M +12.4M +133% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 19M +10.4M +120% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 10.7M +3.78M +54.4% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 9.33M +4.27M +84.5% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q1 2020 8.67M +3.9M +81.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 6.94M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 5.05M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 4.78M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.